Louis W. Sullivan, Director at UNITED THERAPEUTICS Corp (UTHR), sold 30,000 shares at $101.02 ($3.0M) on 2014-05-22, disclosed to the SEC on 2014-05-23.
Scheduled sale ($3.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.02 | 4,900 | $495K | 16.3% |
| 2 | $101.55 | 25,100 | $2.5M | 83.7% |
| Total | $101.46 avg | 30,000 | $3.0M | 100% |
| Filing → |
| UTHR | SELL | 2024-05-06 | $2.7M | — | Filing → |
| UTHR | SELL | 2023-03-02 | $172K | — | Filing → |
| UTHR | SELL | 2023-02-02 | $183K | — | Filing → |